ENTPD1 and neoplasm: Kenison et al. (52) showed that AhR deletion in murine orthotopic oral cancer cells prevents tumor growth and decreases expression of inhibitory immune checkpoints PD-L1, CD39, CTLA-4, PD-1, and Lag3 on multiple immune cell types.